Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 27;11(2):e0005413.
doi: 10.1371/journal.pntd.0005413. eCollection 2017 Feb.

Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species

Affiliations

Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species

Jéssica Cristina Dos Santos et al. PLoS Negl Trop Dis. .

Abstract

Background: Interleukin-32 (IL-32) is expressed in lesions of patients with American Tegumentary Leishmaniasis (ATL), but its precise role in the disease remains unknown.

Methodology/principal findings: In the present study, silencing and overexpression of IL-32 was performed in THP-1-derived macrophages infected with Leishmania (Viannia) braziliensis or L. (Leishmania) amazonensis to investigate the role of IL-32 in infection. We report that Leishmania species induces IL-32γ, and show that intracellular IL-32γ protein production is dependent on endogenous TNFα. Silencing or overexpression of IL-32 demonstrated that this cytokine is closely related to TNFα and IL-8. Remarkably, the infection index was augmented in the absence of IL-32 and decreased in cells overexpressing this cytokine. Mechanistically, these effects can be explained by nitric oxide cathelicidin and β-defensin 2 production regulated by IL-32.

Conclusions: Thus, endogenous IL-32 is a crucial cytokine involved in the host defense against Leishmania parasites.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Leishmania induces IL-32γ expression in a TNFα-dependent manner.
PMA-differentiated THP-1 cells (1 x 106 cells/mL) were infected with promastigote forms (5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz), metacyclic promastigote forms (5 x 106 parasites) of L. (V.) braziliensis (L. braz) or LPS (100 ng/mL) as a positive control during 4 h. Cells were washed to remove non-internalized parasites and incubated for 24 h. (A) mRNA expression of isoforms α, β and γ of IL-32 was determined by quantitative real-time PCR. (B) Intracellular IL-32 protein levels were determined by ELISA in cell lysates. (C) TNFα, IL-8, IL-1β, IL-1Ra, IL-10 productions were determined by ELISA in culture supernatants. (D) Antibodies to TNFα (anti-TNFα, 5 μg/ml) or isotype control (5 μg/mL) were added 30 min before addition of LPS (100 ng/mL) or Leishmania sp. TNFα levels (left panel) and intracellular IL-32 (right panel) were determined by ELISA in supernatants and cell lysates, respectively. Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (Medium vs LPS, L. amaz, L. braz); #p < 0.05 (L. amaz, L. braz).
Fig 2
Fig 2. Intracellular distribution of IL-32 after Leishmania species infection.
PMA-differentiated THP-1 cells (2 x 105 cells/0.5 mL) were infected with promastigote forms (10 x 105 parasites) in stationary phase of growth of L. (L.) amazonensis or metacyclic promastigote forms (10 x 105 parasites) of L. (V.) braziliensis during 4 h. Afterwards, cells were washed to remove non-internalized parasites and incubated for 24 h. Cells were stained for IL-32 (rabbit polyclonal antibody; red), lysosomal-associated membrane protein, LAMP1 (mouse monoclonal antibody; green) and dapi (blue) for confocal microscopy. Yellow colour indicates colocalization of IL-32 and LAMP1. (A) In the eight first images, bar = 20 μm; two inferior images, bar = 10 μm (L. (V.) braziliensis). (B) L. (L.) amazonensis, white arrow heads indicate parasites present in LAMP1+-parasitophorous vacuoles; bar = 10 μm; (C) L. (V.) braziliensis, white arrow heads indicate colocalization of IL-32 and LAMP1 in a LAMP1+-parasitophorous vacuole containing one amastigote (blue), bar = 1 μm; images were took from (A) (left bottom, dashed white squares).
Fig 3
Fig 3. Decrease of cytokine production after IL-32 silencing in THP-1-derived macrophages infected with Leishmania species.
PMA-differentiated THP-1 cells (2.5 x 106 cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 siRNA (for IL-32 knockdown) and control siRNA according to the protocol described in [38]. The final concentration per well was 3 x 105 cells/100 μL. After 24 h of transfection, cells were infected with promastigote forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz) or metacyclic promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h, non-internalized parasites were washed out and cells were incubated for 24 h. (A) mRNA expression of IL-32γ isoform and all isoforms were determined by quantitative real-time PCR. mRNA expression and protein levels of (B) TNFα and IL-8, (C) IL-1β and IL-1Ra and (D) IL-10 were determined by quantitative real-time PCR and ELISA in supernatants, respectively. Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (Control SiRNA vs IL-32 SiRNA); #p < 0.05 (L. amaz, L. braz).
Fig 4
Fig 4. Increased cytokine production after overexpression of IL-32 in human THP-1-derived macrophages infected with Leishmania species.
PMA-differentiated THP-1 cells (2.5 x 106 cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 plasmid (for IL-32 overexpression) and egfp plasmid (as a control) according to the protocol described in [38]. The final concentration per well was 3 x 105 cells/100 μL. After 24 h of transfection, cells were infected with promastigote forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz), metacyclic promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h cells were washed and incubated for 24 h. (A) mRNA expression of IL-32γ isoform and all IL-32 isoforms was determined by quantitative real-time PCR. mRNA expression and protein levels of (B) TNFα and IL-8, (C) IL-1β and IL-1Ra and (D) IL-10 were determined by quantitative real-time PCR and ELISA in supernatants, respectively. Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (egpf plasmid vs IL-32γ plasmid); #p < 0.05 (L. amaz, L. braz).
Fig 5
Fig 5. Silencing of IL-32 in human THP-1-derived macrophages increases Leishmania species infection.
PMA-differentiated THP-1 cells (2.5 x 106 cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 siRNA (for knockdown IL-32) and control siRNA according with protocol described by [38]. The final concentration of cells per well were 3 x 105 cells/100 μL. After 24 h of transfection, cells were infected with promastigotes forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz), metacyclic promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h, cells were washed to remove non-internalized parasites and incubated for 24 h or 48 h. Cells were stained and percentage of infected macrophages, number of parasites per infected cells, and infection index were evaluated. (A) infection with L. amazonensis; (B) infection with L. braziliensis. iNOS (C—left panel), cathelidicin (D—left panel) and β-defensin 2 (E) mRNA expression were determined by quantitative real-time PCR (24 h). Production of nitrite (C—right panel) and LL-37 (D—right panel) was determined by Griess reagent and ELISA in supernatants, respectively (24 h). Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (Control SiRNA vs IL-32 SiRNA).
Fig 6
Fig 6. Decreased Leishmania species infection and increased leishmanicidal molecules after IL-32 overexpression in human THP-1-derived macrophages.
PMA-differentiated THP-1 cells (2.5 x 106 cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 plasmid (for IL-32 overexpression) and egfp plasmid (as a control). The final concentration of cells per well were 3 x 105 cells/100 μL. After 24 h of transfection, cells were infected with promastigote forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz) or metacyclic promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h, non-internalized parasites were washed out and cells were incubated for 24 h or 48 h. Cells were stained and percentage of infected macrophages, number of parasites per infected cells, and infection index were evaluated. (A) infection with L. amazonensis; (B) infection with L. braziliensis. iNOS (C—left panel) and cathelidicin (D—left panel) and β-defensin 2 (E) mRNA expression were determined by quantitative real-time PCR (24 h). Nitrite production (C—right panel) and LL-37 production (D—right panel) were determined by Griess reagent and ELISA in supernatants, respectively (24 h). Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (egpf plasmid vs IL-32γ plasmid).

Similar articles

Cited by

References

    1. Heinhuis B, Netea MG, van den Berg WB, Dinarello CA., Joosten LAB. Interleukin-32: A predominantly intracellular proinflammatory mediator that controls cell activation and cell death. Cytokine. Elsevier Ltd; 2012;60: 321–327. - PubMed
    1. Kang J-W, Park YS, Lee DH, Kim MS, Bak Y, Ham SY, et al. Interaction network mapping among IL-32 isoforms. Biochimie. 2014;101: 248–51. 10.1016/j.biochi.2014.01.013 - DOI - PubMed
    1. Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LAB. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2011;108: 4962–7. 10.1073/pnas.1016005108 - DOI - PMC - PubMed
    1. Kim S-H, Han S-Y, Azam T, Yoon D-Y, Dinarello CA. Interleukin-32. Immunity. 2005;22: 131–142. - PubMed
    1. Choi J-D, Bae S-Y, Hong J-W, Azam T, Dinarello CA., Her E, et al. Identification of the most active interleukin-32 isoform. Immunology. 2009;126: 535–542. 10.1111/j.1365-2567.2008.02917.x - DOI - PMC - PubMed

LinkOut - more resources